"Przyjmujący pacjentów od 1 stycznia 1989 roku Kliniczny Szpital Wojewódzki Nr 2 im. Św. Jadwigi Królowej w Rzeszowie przy ul. Lwowskiej 60 - posiadający 919 łóżek dla dorosłych i dzieci - stanowi kompleks nowoczesnych budynków mieszczących kilkanaście oddziałów, zespoły poradni specjalistycznych oraz zakłady i pracownie diagnostyczne. Kliniczny Szpital Wojewódzki Nr 2 im. Św. Jadwigi Królowej w Rzeszowie będący jedną z największych placówek Ochrony Zdrowia w regionie jako pierwszy otrzymał szereg certyfikatów jakościowych, które świadczą o kompetencji w wykonywaniu świadczeń medycznych."

During the past decade, Szpital Wojewodzki Nr 2 conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Szpital Wojewodzki Nr 2" #1 sponsor was "Allergan" with 2 trials, followed by "Bayer" with 2 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 2 trials sponsored, "AEterna Zentaris" with 1 trials sponsored and "Advanz Pharma" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Szpital Wojewodzki Nr 2" #1 collaborator was "Novo Nordisk A/S" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Szpital Wojewodzki Nr 2" are "Atrial Fibrillation" (2 trials), "Cerebral Palsy" (2 trials), "Muscle Spasticity" (2 trials), "Pediatrics" (2 trials) and "Acute Myocardial Infarction" (1 trials). Many other conditions were trialed in "Szpital Wojewodzki Nr 2" in a lesser frequency.

Most popular intervention types in "Szpital Wojewodzki Nr 2" are "Drug" (7 trials), "Biological" (3 trials), "Device" (2 trials), "Other" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Arginine" (1 trials), "BAY 1753011" (1 trials), "BAY2433334" (1 trials), "BAY2433334 matching placebo" (1 trials) and "Botulinum Toxin Type A" (1 trials). Other intervention names were less common.

The vast majority of trials in "Szpital Wojewodzki Nr 2" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Szpital Wojewodzki Nr 2". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Szpital Wojewodzki Nr 2, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Szpital Wojewodzki Nr 2, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".